期刊文献+

国内外文献对白术内酯Ⅱ抑制肿瘤细胞作用的浓度差异原因分析 被引量:3

Analysis of Different Concentration of Atractylenolide Ⅱ Inhibiting Tumor Cells between the Domestic and Foreign Literature
下载PDF
导出
摘要 目的:国内与国外文献报道白术内酯Ⅱ作用于肿瘤细胞有效剂量差异较大,为探索其实际作用剂量以及出现差异的原因进行实验研究。方法:白术内酯Ⅱ20 mg以DMSO 400μL溶解,并以纯水进一步稀释白术内酯Ⅱ溶液至5、25、50、100、150、300μg/m L,利用紫外分光光度法检测白术内酯Ⅱ实际作用浓度。同法检测胎牛血清、双抗对实际浓度的影响。结果:紫外分光光度法检测上述配制浓度所对应的实际浓度分别为3.81、11.28、13.01、14.94、15.62、17.39μg/m L,并且得出胎牛血清、双抗对白术内酯Ⅱ实际浓度并无影响。结论:国内文献报道白术内酯Ⅱ作用于肿瘤细胞的实际有效浓度与国外文献报道的作用浓度相当,而国内文献报道实验中白术内酯Ⅱ的作用剂量较大的原因并非受培养基影响,而可能与药物溶解度及溶剂相关。 Objective: The domestic and foreign literatures reported different effective dose of AtractylenolideⅡ(AT-Ⅱ),and some experiments need we conduct to explore the actual effective dose of AT-Ⅱ and make sure the reasons for the differences.Methods: 20 mg of AT-Ⅱ was dissolved in 400 μL of DMSO to obtain a concentration of 50×103μg/m L.Further,the above-obtained solution of AT-Ⅱ was diluted to a concentration of5,25,50,100,150,300 μg/m L by water.Then the actual concentration of AT-Ⅱ was determined by ultraviolet spectrophotometry.The effect of fetal bovine serum and double antibody on the actual concentration was detected by the same method.Results: The actual concentration were 3.81,11.28,13.01,14.94,15.62,17.39 μg/m L,and there is no difference whether it contains the fetal bovine serum or double antibody.Conclusion: The effective dose of AT-Ⅱ reported in domestic literatures is larger,and the real concentration of AT-Ⅱ which is effective to the tumor cells reported in China is consistent with the concentration reported overseas.In addition,it is not related to the medium but the solubility of AT-II and the solvent.
出处 《中医药导报》 2017年第20期30-32,共3页 Guiding Journal of Traditional Chinese Medicine and Pharmacy
基金 2015江苏省人社厅"六大人才高峰"第十二批高层次人才选拔培养计划基金资助项目(No.WSW-069) 2015年度江苏省第四期"333工程"科研计划基金资助项目(No.24) 2015年度南京市医学科技发展项目/南京市卫生局重点资助项目(ZKX15040)
关键词 白术内酯Ⅱ 肿瘤细胞 国内外文献 浓度差异 atractylenolide Ⅱ tumor cells domestic and foreign literature concentration difl^rence
  • 相关文献

参考文献2

二级参考文献22

  • 1刘昳,叶峰,邱根全,章梅,王锐,何群英,蔡云.白术内酯Ⅰ对肿瘤恶病质患者细胞因子和肿瘤代谢因子的影响[J].第一军医大学学报,2005,25(10):1308-1311. 被引量:58
  • 2郝延军,桑育黎,李宝林,王勒,贾天柱.白术内酯Ⅰ及白术内酯Ⅲ对唾液淀粉酶活性的影响[J].时珍国医国药,2006,17(9):1617-1618. 被引量:23
  • 3国家药典委员会.中华人民共和国药典(一部).2005年版.北京:化学工业出版社,2005:109.
  • 4Liu Y, Jia Z, Dong L, Wang R, Qiu G. A randomized pilot study of atractylenolide I on gastric cancer ca- chexia patients. Evid Based Complement Alternat Med 2008; 5:337-344 [PMID: 18830451].
  • 5郝延军,桑育黎,王勒,李宝林,贾天柱.白术内酯Ⅰ、Ⅲ对稗虚大鼠胃肠道消化吸收的影响中华中医药学会第瓦届中药炮制学术会议论文集2005:215-217.
  • 6高小玲CT26.~胞RPS20miRNA干扰及体内干扰条件建立.广州中医药大学,2010.
  • 7Wang CC, Lin SY, Cheng HC, Hou WC. Pro-oxi- dant and cytotoxic activities of atractylenolide I in human promyeloleukemic HL-60 cells. Food Chem Toxico12006; 44:1308-1315 [PMID: 16624472].
  • 8Ye Y, Wang H, Chu JH, Chou GX, Chen SB, Mo H, Fong WF, Yu ZL. Atractylenolide II induces G1 cell- cycle arrest and apoptosis in B16 melanoma cells. J Ethnopharmacol 2011; 136:279-282 [PMID: 21524699DOh 10.1016/j.jep.2011.04.020].
  • 9Dong H, He L, Huang M, Dong Y. Anti-inflamma- tory components isolated from Atractylodes mac- rocephala Koidz. Nat Prod Res 2008; 22:1418-1427 [PMID: 19023804 DOI: 10.1080/147864108019316291.
  • 10Liu Y,Jia Z,Dong L,et al.A randomized pilot study of atractylenolide I on gastric cancer cachexia patients.Evid Based Complement Ahemat Med,2008,5(3):337-344.

共引文献35

同被引文献29

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部